In addition, the ARβ inhibitor, propranolol, and the p38 inhibitor, SB203580 significantly inhibited the NE and IL-6R-induced collagen type I production in the SSc fibroblasts (Fig. 5A,B). This evidence concerns the gene IL6R and systemic sclerosis.